IJGC conversations

In this episode of the IJGC podcast, Editor-in-Chief Dr. Pedro Ramirez, is joined by Sarah Andres and Mario M. Leitao Jr to discuss Empty Lymph Node Packet in SLN Mapping for Endometrial Cancer.

 

Sarah Andres, DO, FACOG, is a Gynecologic Oncology Fellow at Memorial Sloan Kettering Cancer Center (MSKCC), with planned graduation in June, 2027. She additionally works within the Weigelt Laboratory conducting translational research and studying rare gynecologic malignancies. Dr. Andres has contributed extensively to the field through her recent research, with work published in leading journals such as Gynecologic Oncology and the International Journal of Gynecological Cancer. Her recent publications explore critical topics including sentinel lymph node mapping techniques in uterine cancer, outcomes of neoadjuvant chemotherapy for advanced ovarian cancer, and genomic characterization of endometrial serous carcinoma. Her clinical and research interests span cervical, endometrial, and ovarian carcinoma, with contributions to multiple clinical trials and retrospective studies.

 

Dr. Mario M. Leitao, Jr., MD, FACOG, FACS, is currently an Attending Surgeon in the Department of Surgery at Memorial Sloan Kettering Cancer Center and a Professor in the Department of Obstetrics and Gynecology at Weill Cornell Medical College. He currently serves as Program Director for the Gynecologic Oncology Fellowship. Dr. Leitao is also the Director for the Minimal Access and Robotic Surgery Program in the Department of Surgery for MSKCC. Dr. Leitao is the recipient of the 2025 IGCS Excellence in Teaching Award.

In this episode of the IJGC podcast, Editor-in-Chief Dr. Pedro Ramirez, is joined by Santiago Vieira-Serna to discuss Contralateral pelvic lymph node metastases in patients with unilateral early-stage epithelial ovarian cancer.

 

Dr. Santiago Vieira-Serna is a gynecologic oncologist who graduated from the Instituto Nacional de Cancerología in Bogotá, Colombia, in 2023. He currently works at the Instituto Nacional de Cancerología and at Clínica Universitaria Colombia.

In this episode of the IJGC podcast, Editor-in-Chief Dr. Pedro Ramirez, is joined by Gabriel Levin to discuss Salpingo-oophorectomy at Radical Hysterectomy for Cervical Adenocarcinoma.

 

Dr. Gabriel Levin is a gynecologic oncologist and clinical researcher at McGill University and the McGill University Health Centre. His work focuses on real-world outcomes research, and health systems innovation in gynecologic cancers. He has authored more than 330 peer-reviewed publications and is actively involved in advancing evidence-based care through academic leadership and international collaboration.

In this episode of the IJGC podcast, Editor-in-Chief Dr. Pedro Ramirez, is joined by Dr. Giuseppe Caruso to discuss Lymphadenectomy in Early-Stage Ovarian Cancer.

 

Dr. Giuseppe Caruso, MD PhD works as a consultant gynecologic oncologist at the European Institute of Oncology (IEO), Milan (Italy), under the mentorship of Prof. Nicoletta Colombo. He holds a PhD in “Network Oncology and Precision Medicine” from the Department of Experimental Medicine, Sapienza University of Rome. He is a research collaborator at Mayo Clinic, Rochester (MN, USA); an honorary faculty member of the European School of Oncology (ESO) College; and a member of the European Network of Young Gynae Oncologists (ENYGO) Executive Group.

In this episode of the IJGC podcast, Editor-in-Chief Dr. Pedro Ramirez, is joined by Dr. Robert Coleman to discuss Vaccine Therapy in Ovarian Cancer: Role of Gemogenovatucel-T.

 

Dr. Coleman completed his Obstetrics & Gynecology residency at Northwestern
University Medical Center in Chicago, Illinois, and completed his fellowship at
The University of Texas MD Anderson Cancer Center in 1993. From 1993-1996,
he served as Assistant Professor at Creighton University followed by service as
Vice-Chairman, Department of Obstetrics and Gynecology at the University of
Texas, Southwestern Medical Center. Dr. Coleman joined as Faculty at MD
Anderson Cancer center in 2004 and served as Professor and Executive Director
for Cancer Network Research, holding the Ann Rife Cox Chair in Gynecology. In
March 2020, he joined US Oncology Research (USOR) as Chief Scientific Officer
and served briefly as Chief Medical Officer for Sarah Cannon Research Institute
(SCRI). He practices at Texas Oncology, US Oncology Network and currently
serves as Chief Medical officer for Vaniam Group. He also serves as Vice
President, GOG Foundation and is Special Advisor to the President for GOG
Partners. Dr. Coleman has authored or coauthored over 800 scientific
publications, including over 500 peer-reviewed articles, along with numerous
book chapters, monographs, invited articles, and textbooks. He was the 2019
APGO-CREOG awardee for Excellence in Teaching. He serves as Vice President
of GOG-Foundation, Inc. He served as President of the Society of Gynecologic
Oncology (SGO, 2015-2016) and President of International Gynecologic Cancer
Society (IGCS, 2020-2022). He was inducted into MJH Life Sciences™ 2020
class of “Giants in Cancer Care®.”